Serum matrix metalloproteinase 3 levels during treatment with sulfasalazine or combination of methotrexate and sulfasalazine in patients with early rheumatoid arthritis. [electronic resource]
Producer: 20021119Description: 883-9 p. digitalISSN:- 0315-162X
- Adult
- Aged
- Antirheumatic Agents -- administration & dosage
- Arthritis, Rheumatoid -- blood
- C-Reactive Protein -- metabolism
- Cohort Studies
- Drug Therapy, Combination
- Female
- Follow-Up Studies
- Humans
- Male
- Matrix Metalloproteinase 3 -- blood
- Methotrexate -- administration & dosage
- Middle Aged
- Prospective Studies
- Sulfasalazine -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.